Correction to: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England (Nature Communications, (2024), 15, 1, (3822), 10.1038/s41467-024-47745-z)
Copland E., Patone M., Saatci D., Handunnetthi L., Hirst J., Hunt DPJ., Mills NL., Moss P., Sheikh A., Coupland CAC., Harnden A., Robertson C., Hippisley-Cox J.
Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-47745-z, published online 27 May 2024 The original version of this article contained information on vaccine dose amount (full or half) in Table 2 and Supplementary Table 1. This has subsequently been found to be inaccurate due to inconsistent coding in the raw data. The vaccine dose amount has therefore been removed from Table 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. An additional line has been added to the introduction to summarise vaccine doses that were given to the population: “Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micrograms), and children aged 5–11 years were given a dose of 10 micrograms of BNT162b2 vaccine.” These changes have been made in the PDF and HTML versions of the article.